MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0002641
MDC Pharmaceuticals Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹61.89 Cr
▲ 14% YoY
Net profit · FY 2024
₹2.21 Cr
Net margin 3.6%
EBITDA · FY 2024
₹5.43 Cr
EBITDA margin 8.8%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹12.24 Cr
Issued & subscribed
Open charges
₹37.85 Cr
Satisfied ₹44.98 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
44
Provident fund records
About MDC Pharmaceuticals Limited
Data last updated:
MDC Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 July 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH1994PLC014820. Its GSTIN is 04AACCM4527B2Z1 (Chandigarh). The company holds 13 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹12.24 Cr. It was formerly known as Mdc Pharmaceuticals Pvt Ltd. It is led by directors including Parvinder Singh Gulati (Whole-Time Director) and Gurmeet Singh Narula (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 46 Industrial Area Phase II, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.89 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹2.21 Cr (net margin 3.6%) and EBITDA of ₹5.43 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 2% over five years.
The company has about 44 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: MDC Pharmaceuticals and MDC Pharmaceutical. As per MCA filings, the company has open charges of ₹37.85 Cr and satisfied charges of ₹44.98 Cr on record. Court records list 19 cases involving the company, including 10 filed by the company and 6 filed against it; 5 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹5.01 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Terratech Intermediates (India) Private Limited with revenue of ₹62.41 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 22 overdue payments to 22 micro and small suppliers.
MDC Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002641). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mdcpharmaceutical.com.
Company Details of MDC Pharmaceuticals Limited
CIN U24231CH1994PLC014820
Registration Number 014820
Incorporation Date 14 July 1994
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0002641
CIN History of MDC Pharmaceuticals Limited
MDC Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231CH1994PTC014820. The current CIN is U24231CH1994PLC014820, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231CH1994PLC014820 | Current |
| U24231CH1994PTC014820 | Previous |
Key People
Parvinder Singh Gulati Whole-Time Director Gurmeet Singh Narula Whole-Time Director Sham Lal Singla Whole-Time Director Recognitions & Rankings of MDC Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 46 Industrial Area Phase II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
MDC Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with MDC Pharmaceuticals Limited
MDC Pharmaceuticals operates two associated brands: MDC Pharmaceuticals and MDC Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces and distributes derma care and nutraceutical products through franchises. | lifestylebiosciencedermacare.com | |
| Pharmaceutical manufacturing, franchise services, and product distribution in India. | mdcpharmaceutical.com |
Business Activity of MDC Pharmaceuticals Limited
The main business activity of MDC Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MDC Pharmaceuticals Limited FY 2024 filings available
MDC Pharmaceuticals Limited reported revenue of ₹61.89 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹61.89 Cr ▲ 14%
Net profit · FY 2024
₹2.21 Cr margin 3.6%
EBITDA · FY 2024
₹5.43 Cr margin 8.8%
Compounded Annual Growth Rate (CAGR) of MDC Pharmaceuticals Limited
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 8%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 27%
5 years · compounded
▼ 14%
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 14% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MDC Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹61.89 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.21 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MDC Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MDC Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors and KMP of MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited currently reports 8 directors and 1 key managerial person. 3 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harkanwal Kaur Bhatia Also directs: Brand Toniq LLP | Director | 26 Feb 2018 | 8 Years 7 Months | Current |
| Parvinder Singh Gulati Also directs: Lifestyle Bio Sciences Private Limited, Glopetra Cosmetics Private Limited, MDC Global Welfare Foundation and 5 more | Whole-Time Director | 14 Jul 1994 | 32 Years 3 Months | Current |
| Manisha Sharma | Director | 26 Feb 2018 | 8 Years 7 Months | Current |
| Gurmeet Singh Narula Also directs: Lifestyle Bio Sciences Private Limited, Moselle Drugs and Cosmetics Limited, Glopetra Cosmetics Private Limited and 4 more | Whole-Time Director | 14 Jul 1994 | 32 Years 3 Months | Current |
| Ravdeep Singh Matta Also directs: Jasco Propack Private Limited, Horizon Offset Private Limited, Jasco Labs Private Limited and 2 more | Director | 26 Feb 2018 | 8 Years 7 Months | Current |
| Pramila Devi Also directs: Infiscale Technologies Private Limited | Cfo | 09 Feb 2018 | 8 Years 8 Months | Current |
Showing 6 of 9 current directors and KMP. View all directors and KMP
Peer Comparison of MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Terratech Intermediates (India) Private Limited | ₹62.41 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Ahmedabad, Gujarat, India |
| Shamshree Lifesciences Limited | ₹62.27 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Cian Healthcare Limited Listed | ₹62.14 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Pune, Maharashtra, India |
| Enanti Labs Private Limited | ₹62.07 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| AAA Pharmatrade Private Limited | ₹61.98 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | New Delhi, Delhi, India |
| MDC Pharmaceuticals Limited this company | ₹61.89 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Chandigarh, India |
| DNV Overseas Impex Private Limited | ₹61.67 Cr (FY 2018) | •••• | •••• | 74.0% | •••• | New Delhi, Delhi, India |
| Unijules Life Sciences Limited | ₹61.64 Cr (FY 2018) | •••• | •••• | -4.0% | •••• | Nagpur, Maharashtra, India |
| Imperia Life Sciences Private Limited | ₹61.51 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Vadodara, Gujarat, India |
| Revat Laboratories Private Limited | ₹61.45 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Hyderabad, Telangana, India |
| Gelnova Laboratories (India) Private Limited | ₹61.38 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below MDC Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited is audited by GAMBHIR KHURANA & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GAMBHIR KHURANA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of MDC Pharmaceuticals Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MDC Pharmaceuticals Limited
Open charges
₹37.85 Cr
Satisfied charges
₹44.98 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2025 | Hdfc Bank Limited | ₹2 Cr | Open |
| 04 Jul 2025 | Hdfc Bank Limited | ₹52.27 Lakh | Open |
| 02 Apr 2025 | Hdfc Bank Limited | ₹68.05 Lakh | Open |
| 04 May 2024 | Hdfc Bank Limited | ₹2 Cr | Open |
| 29 Apr 2024 | Hdfc Bank Limited | ₹2 Cr | Open |
Total charge records: 25 View all charges
Deals & Funding of MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹5.01 Cr; the latest was in March 2021.
Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹5.01 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2020 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Rahul Jain HUF, 3 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Narender Gupta HUF, 3 individuals |
| Apr 2018 | Funding round | ₹5.01 Cr | Investors: 4 individuals |
Premium access
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited has 19 court cases on record: 10 filed by MDC Pharmaceuticals, 6 filed against it, 3 where it is another party. 5 cases are pending and 14 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Total cases
19
Filed by the company
10
Filed against the company
6
Pending
5
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 10 | 1 | 1 |
| District courts | 7 | 3 | 4 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Remedi Speciality Medicines LLP | Disposed |
| Supreme Court | Special leave petition | Filed against the company by Overseas Health Care Private Limited | Disposed |
| District court, Thrissur, Kerala | Court case (Crl MP) | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (COMIP) | Company is another party | Pending |
| District court, Prakasham, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
Premium access
Full case history
All 19 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 22 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Symbio Generics India Private Limited | •••• | •••• | •••• |
| Kenergie Industries Private Limited | •••• | •••• | •••• |
| Maya Biotech Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited has a workforce of 44 employees as of Mar 28, 2024.
Employee count
44
Active EPFO establishments
2
Employee growth
-80.27%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of MDC Pharmaceuticals Limited
MDC Pharmaceuticals has 3 associated companies. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
3
Associated companies
Recent Activity on MDC Pharmaceuticals Limited
MDC Pharmaceuticals Limited has 12 board changes on record since 1994: 9 appointments and 3 cessations. The latest: Gurmeet Singh Narula ceased to be Director on 26 Feb 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.00 Cr with Charge ID 101190869 was registered on 06 Nov 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.52 Cr with Charge ID 101129034 was registered on 04 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.68 Cr with Charge ID 101083808 was registered on 02 Apr 2025.
AGM
Mdc Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 15 Jan 2022 via Charge ID 100530740 with Hdfc Bank Limited was fully satisfied on 09 Sep 2024.
Charges
A charge registered on 29 May 2021 via Charge ID 100449221 with Axis Bank Limited was fully satisfied on 05 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100920206 was registered on 04 May 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100920197 was registered on 29 Apr 2024.
Charges
A charge registered on 11 Oct 2023 via Charge ID 100806573 with Hdfc Bank Limited was fully satisfied on 26 Apr 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100920835 was registered on 25 Apr 2024.
Filing
Mdc Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited of Rs. 5.00 Cr registered on 19 Oct 2023 with Charge ID 100809386 was modified on 13 Mar 2024.
44 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for MDC Pharmaceuticals Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MDC Pharmaceuticals Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MDC Pharmaceuticals Limited
MDC Pharmaceuticals has 13 GST registrations: 5 active and 8 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
13
Active
5
Cancelled / inactive
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCM4527B2Z1 | Chandigarh | Active | 19 Aug 2017 |
| 02AACCM4527B2Z5 | Himachal Pradesh | Active | 01 Jul 2017 |
| 18AACCM4527B1ZT | Assam | Active | 29 Jun 2019 |
| 32AACCM4527B1Z3 | Kerala | Active | 09 Jul 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MDC Pharmaceuticals Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MDC Pharmaceuticals Limited
MDC Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 July 1994 (32+ years old) and is registered under CIN U24231CH1994PLC014820.
MDC Pharmaceuticals reported revenue of ₹61.89 Cr for FY 2024 (up 14% YoY).
MDC Pharmaceuticals has 9 current directors and KMP:
- Parvinder Singh Gulati - Whole-Time Director
- Gurmeet Singh Narula - Whole-Time Director
- Sham Lal Singla - Whole-Time Director
- Harkanwal Kaur Bhatia - Director
- Manisha Sharma - Director
- Ravdeep Singh Matta - Director
- Vir Pal Singh - Director
- Jatinder Singh Wig - Director
- Pramila Devi - Cfo
MDC Pharmaceuticals reported a net profit of ₹2.21 Cr (net margin 3.6%) and EBITDA of ₹5.43 Cr (EBITDA margin 8.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MDC Pharmaceuticals is 8% over three years and 2% over five years. In the latest year (FY 2024) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MDC Pharmaceuticals is 04AACCM4527B2Z1, registered in Chandigarh. The company has 13 GST registrations in all, of which 5 are active and 8 are cancelled or inactive. Other active GSTINs include 02AACCM4527B2Z5 (Himachal Pradesh), 18AACCM4527B1ZT (Assam), 32AACCM4527B1Z3 (Kerala).
The CIN (Corporate Identification Number) of MDC Pharmaceuticals is U24231CH1994PLC014820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MDC Pharmaceuticals has 19 court cases on record: 10 filed by the company and 6 filed against it. 5 are pending. Most are in the high courts.
MDC Pharmaceuticals was incorporated on 14 July 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chandigarh.
MDC Pharmaceuticals has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹5.01 Cr; the latest was in March 2021.
The peers of MDC Pharmaceuticals by revenue are Terratech Intermediates (India) Private Limited, Shamshree Lifesciences Limited, Cian Healthcare Limited, Enanti Labs Private Limited, AAA Pharmatrade Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Gurmeet Singh Narula ceased to be Director on 26 Feb 2018. Harkanwal Kaur Bhatia was appointed as Director on 26 Feb 2018. Jatinder Singh Wig was appointed as Director on 26 Feb 2018. MDC Pharmaceuticals has 12 board changes on record in total.